Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Up-regulated lung cancer 10 protein (URLC10) is a human protein identified as being overexpressed in lung cancer tissues. Its gene, URLC10, has been specifically noted for its increased expression in the context of lung malignancies. The upregulation of this protein suggests a potential role in tumorigenesis or progression of lung cancers. URLC10 may serve as a diagnostic biomarker for certain types of lung cancer and could be explored as a prognostic indicator.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Up-regulated in lung cancer 10 protein (URLC10).